Fortress Biotech, Inc.
Status: Publicly traded
Direct answer
Fortress Biotech, Inc. is publicly traded on NASDAQ under the ticker FBIO.
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases). Other products...
Can you invest in Fortress Biotech, Inc.?
Yes. Fortress Biotech, Inc. is publicly traded on NASDAQ under the ticker FBIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fortress Biotech, Inc.
Detailed equity research is provided by MarketSnap.